By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1 North Waukegan Road

North Chicago  Illinois  60064  U.S.A.
Phone: 1-800-255-5162 Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


Company News
AbbVie (ABBV) To Host Third-Quarter Earnings Conference Call 10/6/2015 9:46:02 AM
AbbVie (ABBV) Demonstrates Leadership In Dermatology With 26 Abstracts At The European Academy Of Dermatology And Venereology Congress 10/5/2015 7:59:01 AM
AbbVie (ABBV) Demonstrates Commitment To Hepatitis C Patients With New Data On VIEKIRA PAK (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) And Ongoing Clinical Development Program At The Liver Meeting 2015 10/2/2015 6:18:59 AM
AbbVie (ABBV)'s VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval In Japan For The Treatment Of Genotype 1 Chronic Hepatitis C 9/28/2015 7:22:19 AM
AbbVie (ABBV) Walks Away from $1.4 Billion Arthritis Deal with Galapagos (GLPG.BR) to Develop Its Own Drug Instead 9/25/2015 7:01:55 AM
AbbVie (ABBV)'s Arthritis Drug Meets Primary Endpoint in Two Phase II Studies 9/25/2015 6:12:47 AM
Gilead (GILD) Beats AbbVie (ABBV) Again 9/22/2015 7:01:27 AM
AbbVie (ABBV) Joins Biotech Influx into Crowded Cambridge with New Research Facility 9/18/2015 7:23:22 AM
AbbVie (ABBV) Announces Plans To Proceed To Phase 3 Evaluation Of Elagolix In Patients With Uterine Fibroids 9/16/2015 7:29:03 AM
AbbVie (ABBV) Announces Submission Of A Supplemental New Drug Application For IMBRUVICA (ibrutinib) For Treatment-Naive Chronic Lymphocytic Leukemia 9/14/2015 7:08:41 AM